开盘$13.94
昨收$14.12
当日区间$13.32 – $14.13
成交量871.9K
市值$1.04B
市盈率（TTM）78.9
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例106.6%+0.04 个百分点，较上季度
持仓机构数260-1 ，较上季度
内部人近期交易28次买入 / 19次卖出净买入
空头持仓比例9.41% 占流通股回补天数 5.5 · 截至 15 Oct 2026
卖空成交量占比27.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$3.95M（4个净流入日，16个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有43.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从8.33%升至9.41%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Access Investment Management, LLC | Mutual Fund | 2026/Q3 | +159,980 | 0.7% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +160,130 | 0.2% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +816,894 | 1.9% |
| Integral Health Asset Management, LLC | Hedge Fund | 2026/Q3 | +550,000 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +364,934 | 13.7% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +354,779 | 4.4% |
| PFM Health Sciences, LP | Hedge Fund | 2026/Q3 | +348,746 | 0.4% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +287,597 | 3.0% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +230,554 | 0.3% |
| Nuveen Investments | Mutual Fund | 2026/Q3 | +205,134 | 0.3% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +176,254 | 0.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +160,814 | 1.9% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q3 | +149,703 | 0.8% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +134,650 | 2.3% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +131,515 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | Andrea Caruso | CVP & CHRO | Initial Statement of Beneficial | +0 | – | 24,211 |
| 16 Sep 2026 | Lesha Shinn | Initial Statement of Beneficial | +0 | – | 26,838 | |
| 31 Aug 2026 | Chantal Veillon-Berteloot | Former Chief Human Resources Officer | Sale to Issuer | -1,455 | $16.62 | 20,772 |
| 2 Jul 2026 | Lea Knight | Chief Financial Officer | Sale to Issuer | -5,226 | $18.05 | 45,263 |
| 30 Jun 2026 | Robert Davis | Executive Vice President of Tissue Reconstruction and Distributed Technologies | Other Derivative Acquisition | +11,180 | – | 54,530 |
| 30 Jun 2026 | Jeffrey Mosebrook | Senior VP of Finance & Principal Accounting Officer | Sale to Issuer | -937 | $17.89 | 34,516 |
| 30 Jun 2026 | Harvinder Singh | Executive VP & President of International Business | Other Derivative Acquisition | +5,590 | – | 68,883 |
| 31 May 2026 | Stuart Essig | Chief Executive Officer | Other Derivative Acquisition | +365,297 | – | 365,297 |
| 31 May 2026 | Stuart Essig | Chief Executive Officer | Other Derivative Acquisition | +705,468 | $15.67 | 705,468 |
| 31 May 2026 | Michael McBreen | Executive Vice President | Other Derivative Acquisition | +31,909 | – | 124,017 |
| 31 May 2026 | Michael McBreen | Executive Vice President | Other Derivative Acquisition | +60,372 | $15.67 | 60,372 |
| 8 May 2026 | Keith N. Bradley | Independent Director | Sale to Issuer | -882 | $13.92 | 88,254 |
| 6 May 2026 | Christian Schade | Independent Director | Other Derivative Acquisition | +17,700 | – | 17,700 |
| 6 May 2026 | Barbara Hill | Independent Director | Other Acquisition | +24,338 | – | 187,541 |
| 6 May 2026 | Keith N. Bradley | Independent Director | Other Derivative Acquisition | +17,700 | – | 17,700 |
| 6 May 2026 | Jeffrey Graves | Independent Director | Other Derivative Acquisition | +17,700 | – | 17,700 |
| 6 May 2026 | Shaundra Clay | Independent Director | Other Derivative Acquisition | +17,700 | – | 17,700 |
| 6 May 2026 | Renee Lo | Independent Director | Other Derivative Acquisition | +17,700 | – | 17,700 |
| 10 Mar 2026 | Robert Davis | Executive Vice President of Tissue Reconstruction and Distributed Technologies | Other Derivative Acquisition | +43,350 | – | 43,350 |
| 10 Mar 2026 | Mojdeh Poul | Former Chief Executive Officer | Other Derivative Acquisition | +343,393 | – | 445,691 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 7,316,999 | 9.4% | 5.5 |
| 30 Sep 2026 | 7,266,960 | 9.3% | 7.5 |
| 15 Sep 2026 | 6,806,086 | 8.8% | 8.3 |
| 31 Aug 2026 | 6,858,036 | 8.8% | 12.3 |
| 14 Aug 2026 | 6,742,359 | 8.7% | 10.0 |
| 31 Jul 2026 | 6,477,081 | 8.3% | 5.9 |
暂无评论——快来第一个聊聊 IART。